PMGC Holdings Inc.

Stage 4 · Declining · week 107

As of Oct 22, 2026, PMGC Holdings is in Stage 4, the downtrend phase, now in week 107 (since Sep 9, 2024). It closed at $2.66, 99.8% below its 52-week high and below its 200-day average, which is falling.

$2.66

-7.04% today

$2.2M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is ELAB early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-11-21 → 2026-10-22

S? 42w

S4 111w

2023-11-212026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S? 42w → S4 111w current

Total tracked: 152 weeks across 2 stage runs.

ELAB among Biotechnology553rd of 591 by relative strength

All 591 →

Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	GTBPGT Biopharma, Inc.	Stage 2 · wk 7	99	−22.3%
2	IOVAIovance Biotherapeutics, Inc.	Stage 2 · wk 18	99	+38.8%
3	SLSSELLAS Life Sciences Group, Inc.	Stage 3 · wk 4	99	−1.5%
4	MRNAModerna, Inc.	Stage 2 · wk 17	99	+11.3%
5	TWSTTwist Bioscience Corporation	Stage 2 · wk 39	99	−14.5%
6	KODKodiak Sciences Inc	Stage 2 · wk 4	99	+172.1%
7	ERASErasca, Inc.	Stage 3 · wk 5	99	+0.7%
8	CLYMClimb Bio, Inc.	Stage 3 · wk 3	99	−15.8%
…553	ELABPMGC Holdings Inc.	Stage 4 · wk 107	2	−41.3%

vs 52W High

-99.8%

$2.66 lo$1,483.20 hi

99.8% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 107

1w13w26w

Week 107, extended decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-94.0%

200 DMA: $44.31 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.10x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-41.3%

-70.4%

-91.0%

YTD

-99.2%

-99.8%

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-10-22S4

Wk 107 · Vol 0.10x

2026-10-21S4

Wk 107 · Vol 0.05x

2026-10-20S4

Wk 107 · Vol 0.09x

2026-10-19S4

Wk 106 · Vol 0.09x

2026-10-16S4

Wk 106 · Vol 0.25x

2026-10-15S4

Wk 106 · Vol 0.31x

2026-10-14S4

Wk 106 · Vol 0.22x

2026-10-13S4

Wk 106 · Vol 0.26x

2026-10-12S4

Wk 105 · Vol 0.16x

2026-10-09S4

Wk 105 · Vol 0.08x

2026-10-08S4

Wk 105 · Vol 0.31x

2026-10-07S4

Wk 105 · Vol 0.37x

Moving averages & range

50 DMA

$4.67

200 DMA

$44.31

52W High

$1,483.20

52W Low

$2.66

5D Low

$2.66

Resistance levels (recent highs)

20d High

$4.78

60d High

$9.84

120d High

$23.30

250d High

$1,449.60

Next resistance

+79.7%

to 20d High

ROE

-105.2%

Profit margin 0.0%

Dividend Yield

0.00%

P/B 0.1

PMGC Holdings: quick answers

What stage is PMGC Holdings in?

As of Oct 22, 2026, PMGC Holdings (ELAB) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 9, 2024 and is in week 107. What the four stages mean

Is PMGC Holdings in an uptrend?

No. PMGC Holdings is in a Stage 4 downtrend. It trades 94.0% below its 200-day average, which is falling.

How far is PMGC Holdings from its 52-week high?

PMGC Holdings closed at $2.66 on Oct 22, 2026, 99.8% below its 52-week high of $1,483.20. Its 52-week low is $2.66.

How has PMGC Holdings performed over the past year?

As of Oct 22, 2026, PMGC Holdings is down 99.8% over the past year and down 99.2% so far in 2026.

Which sector and industry is PMGC Holdings in?

PMGC Holdings is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

PMGC Holdings Inc., doing business as NorthStrive Holdings, Inc, a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operating investment firms; providing packaging solutions to industrial and consumer markets; and design and production of high-tolerance components for industrial and technological applications. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.